Skip to content

Relieva Tract RT1240AZ

by Acclarent, Inc.

Relieva Tract RT1240AZ is a Class I device made by Acclarent, Inc., cleared under FDA 510(k) K183090 on 19 Apr 2019 and listed in FDA GUDID since 31 May 2019 (UDI-DI 20705031462615), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

510(k) K183090

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number20705031462615 UDI-DI Date31 May 2019ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK183090 Date19 Apr 2019DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K183090 decided 19 Apr 2019 Active
  • FDA GUDID UDI-DI 20705031462615 listed 31 May 2019 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K183090
  2. Listed FDA GUDID 20705031462615

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Relieva Tract
Generic name
Nasal/paranasal balloon catheter, non-tracking
Model / Ref / Catalog
RT1240AZ
Primary DI / UDI-DI
20705031462615
510(k) Number
FDA product code
QGK
GMDN term
Nasal/paranasal balloon catheter, non-tracking
Device class
Class I
Regulation number
874.4420
GUDID distribution status
In Commercial Distribution

Other devices from Acclarent, Inc.

See all devices from Acclarent, Inc. →

Properties

  • Supplied sterile
  • Single use
  • Prescription use
  • Lot / batch number
  • Expiration date
  • Manufacturing date
Other properties (9, all answered No)